Tag: Lenvatinib

Home / Lenvatinib

Categories

The FDA has approved the combination of lenvatinib and pembrolizumab for advanced renal cell carcinoma

August 2021: The combination of lenvatinib (Lenvima, Eisai) and pembrolizumab (Keytruda, Merck) has been approved by the Food and Drug Administration for the first-line treatment of adult patients wit...
lenvatinib

Pembrolizumab and lenvatinib have been approved by the FDA for advanced endometrial cancer

August 2021: Pembrolizumab (Keytruda, Merck) in combination with lenvatinib (Lenvima, Eisai) has been approved by the Food and Drug Administration for patients with advanced endometrial carcinoma that...
lenvatinib

Scan the code